Suscribirse

Examining the potential risk factors for variable airflow limitation in patients recovering from SARS-CoV-2 Omicron variant infection: A case-control study - 20/04/24

Doi : 10.1016/j.ajic.2023.11.015 
Lihong Zhao, MM, Chunfang Wang, MB, Jinxin Song, MB, Ping Jiang, PhD
 Department of Respiratory and Critical Care Medicine, Tianjin First Central Hospital, Tianjin, China 

Address correspondence to Ping Jiang, PhD, Department of Respiratory and Critical Care Medicine, Tianjin First Central Hospital, No. 24 Fukang Road, Nankai District, Tianjin 300000, China.Department of Respiratory and Critical Care Medicine, Tianjin First Central HospitalNo. 24 Fukang Road, Nankai DistrictTianjin300000China

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Resumen

Background

The Omicron strain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread globally. However, it remains uncertain whether variable airflow limitation (VAL) occurs during the recovery phase after contracting the Omicron variant. To address this question, we conducted a study to examine the occurrence of VAL in patients infected with the Omicron variant (BA.1) of SARS-CoV-2, and we also investigated the potential risk factors associated with this phenomenon.

Methods

We summarized and analyzed data taken from the electronic health records of recovering patients who had contracted the Omicron variant. The information was obtained from the Shuixi Branch of our Hospital during the period from January 22 to February 24, 2022. We focused on examining the occurrence of VAL and identifying the associated risk factors among these patients.

Results

In this case-control study, a total of 176 patients were enrolled. The occurrence of VAL was observed in 9.66% (17 individuals). Patients with VAL showed significantly elevated levels of the modified Borg dyspnea score, daytime cough score, night-time cough score, chest computed tomography severity score, and Treg ratio compared to those without VAL. Additionally, patients with VAL had a lower 6MWD value compared to those without it. Logistic regression analysis demonstrated that the modified Borg dyspnea score independently increased the risk of Omicron infection with VAL, with an odds ratio of 3.375, and a 95% confidence interval ranging from 1.537 to 7.408, with a P-value of .002.

Conclusions

There is a possibility of experiencing VAL in certain patients recovering from the SARS-CoV-2 Omicron variant infection. The modified Borg dyspnea score has been identified as a standalone risk factor for the occurrence of VAL in SARS-CoV-2 Omicron infection.

El texto completo de este artículo está disponible en PDF.

Highlights

Certain patients may experience VAL in recovery of Omicron infection.
Modified Borg dyspnea score is a risk factor for VAL in Omicron.
Assess and monitor cough, dyspnea, chest CT, and lung function to identify these patients.

El texto completo de este artículo está disponible en PDF.

Key Words : Modified Borg dyspnea score, 6-minute walk distance, Treg ratio


Esquema


 Funding/support: This study was supported by the Tianjin Science and Technology Commission (No. 22HHXBJC00001).
 Conflicts of interest: Authors state no conflict of interest.


© 2023  Association for Professionals in Infection Control and Epidemiology, Inc.. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 52 - N° 5

P. 541-545 - mai 2024 Regresar al número
Artículo precedente Artículo precedente
  • Effect of chronic diseases on willingness to receive the second COVID-19 vaccine booster dose among cancer patients: A multicenter cross-sectional survey in China
  • Mufan Li, Yizhou Ren, Ping Liu, Jiayu Wang, Ying Wang, Junjie Xu, Jianzhou Yang
| Artículo siguiente Artículo siguiente
  • The impact of COVID-19 on antibiotic resistance and clinical outcomes among critically ill patients
  • Khaled Al Oweidat, Ahmad A. Toubasi, Farah A. Khraisat, Moayad N. Aldahabi, Ahmad Alghrabli, Yasmeen Khater, Noor Saleh, Thuraya N. Al-Sayegh, Asma S. Albtoosh

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.